Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice
2019 · Frontiers in Pharmacology · 48 citations
https://doi.org/10.3389/fphar.2019.01044
M
Michael G. Brant
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
276
Citations
11
h-index
11
i10-index
Michael G. Brant is an academic researcher from Zymeworks (Canada). The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Cancer therapeutics and mechanisms. The author has an h-index of 11, co-authored 40 publications.
ORCID: 0000-0002-1950-1070Papers by this author
worksSupplementary Table S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735676.v1
Supplementary Figure S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735688
Supplementary Table S2 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735676
Supplementary Table S3 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735670
Synthetic Procedures from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735667
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat